Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 2439-2448

  Bertoletti, Antonio ^a,c   Cham, Fatim ^a   McAdam, Stephen ^b   Rostron, Tim ^b   Rowland Jones, Sarah ^b   Sabally, Sehu ^a   Corrah, Tumani ^a   Ariyoshi, Koya ^a   Whittle, Hilton ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HLA ANTIGEN CLASS 1;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HLA TYPING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031888680     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.2439-2448.1998     Document Type: Article

References (41)

1. Aaby, P., A.-G. Poulsen, O. Larsen, C. B. Christiansen, H. Jensen, M. Melbye, A. Naucler, and F. Dias. 1997. Does HIV-2 infection provide cross-protection against HIV-1 infection? AIDS 7:939-940. (Letter.)
2. Abimiku, A. G., G. Franchini, J. Tartaglia, K. Aldrich, M. Myagkikh, P. D. Markham, P. Chong, M.-P. Klein, M. Kieny, E. Paoletti, R. C. Gallo, and M. Robert-Guroff. 1995. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques. Nat. Med. 1:321-329.
3. Allsopp, C. E. M., R. M. Harding, C. Taylor, M. Bunce, D. Kwiatkowski, N. Anstey, D. Brewster, A. J. McMichael, B. M. Greenwood, and A. V. S. Hill. 1992. Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am. J. Hum. Genet. 50:411-421.
4. Anderson, R. W., J. R. Bennick, J. W. Yewdell, W. L. Maloy, and J. E. Coligan. 1992. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes. Mol. Immunol. 29:1089-1095.
5. Ariyoshi, K., F. Cham, N. Berry, S. Jaffar, S. Sabally, T. Corrah, and H. Whittle. 1995. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS 9:555-559.
6. Ariyoshi, K., M. Schim van der Loeff, S. Sabally, F. Cham, T. Corrah, and H. Whittle. 1997. Does HIV-2 infection provide cross-protection against HIV-1 infection? AIDS 11:1053-1054. (Letter.)
7. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonist for antiviral cytotoxic T cells. Nature 369:407-410.
8. Bunce, M., C. M. O'Neil, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355-367.
9. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-487.
10. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655-663.
11. Falk, K., O. Rotzschke, M. Takiguchi, V. Ganu, S. Stevanovic, G. Jung, and H. G. Rammensee. 1995. Peptide motifs of HLA-B58, B60, B61, and B62 molecules. Immunogenetics 41:165-168.
12. Flynn, J. N., P. Keating, M. J. Hosie, M. Mackett, E. B. Stephens, J. A. Beatty, J. C. Neil, and O. Jarrett. 1995. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J. Immunol. 157:3658-3665.
13. Gallimore, A., M. Cranage, N. Cook, N. Almond, J. Bootman, E. Rud, P. Silvera, M. Dennis, T. Corcoran, J. Stott, and F. M. Gotch. 1995. Early suppression of SIV replication by CD8+ nef-specinc cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1167-1173.
14. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-141.
15. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-298.
16. Goulder, P. J. R., M. Bunce, P. Krausa, K. McIntyre, S. Crowley, B. Morgan, A. Edwards, P. Giangrande, R. E. Philips, and A. J. McMichael. 1996. Novel, cross-restricted, conserved and immunodominant CTL epitopes in slow progressors in HIV-1 infection. AIDS Res. Hum. Retroviruses 12:1891-1896.
17. Guyader, M., M. Emerman, P. Sonigo, F. Clavel, L. Montangier, and M. Alizon. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326:662-669.
18. Kalams, S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. D'Aquila, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
19. Kersh, G. J., and P. M. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature 380:495-498.
20. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. M. Keet, J.-K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressor and long-term asymptomatics. J. Exp. Med. 181:1365-1372.
21. Klenerman P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D.. Lalloo, B. Koppe, A. Edwards, R. E. Philips, and A. J. McMichael. 1994. Naturally occuring HIV-1 gag variants antagonise cytotoxic T-cell activity. Nature 369:403-407.
22. + cytotoxic T cells. J. Virol. 67:4086-4094.
23. Marlink, R. 1996. Lessons from the second AIDS virus, HIV-2. AIDS 10: 689-699.
24. Maryanski, J. L., C. V. Jongeneel, P. Bucher, J. L. Casanova, and P. R. Walker. 1996. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity 4:47-55.
25. McAdam, S., P. Kaleebu, P. Krausa, P. Goulder, N. French, B. Collin, T. Blanchard, J. Whitworth, A. McMichael, and F. Gotch. Cross-clade recognition of P55 by cytotoxic T lymphocytes in HIV-1. Submitted for publication.
26. Moss, B., and C. Flexener. 1987. Vaccinia virus expression vectors. Annu. Rev. Immunol. 5:305-324.
27. Nixon D. F., A. R. M. Townsend, J. G. Elvin, C. R. Rizza, J. Gallwey, and A. J. McMichael. 1988. HIV-1 gag-specific CTL defined with recombinant vaccinia viruses and synthetic peptides. Nature 336:484-487.
28. Nixon, D. F., S. Heut, J. Rothbard, M.-P. Kieny, M. Delchambre, C. Thiriart, C. R. Rizza, F. M. Gotch, and A. J. McMichael. 1990. An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. AIDS 4:841-845.
29. Pantaleo, G., J. F. Demarest, H. Soudeyns, C. Graziosi, F. Denis, J. W. Adelsberger, P. Borrow, M. S. Saag, G. M. Shaw, R. P. Sekaly, and A. S. Fauci. 1994. Major expansion of CD8+ T cells with a predominant Vb usage during the primary immune response to HIV. Nature 370:463-467.
30. Pircher, H., A. Moskphidis, U. Rohrer, K. Burki, H. Hengartner, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633.
31. Poulsen, A.-G., P. Aaby, O. Larsen, H. Jensen, A. Naucler, I. M. Lisse, C. B. Christiansen, F. Dias, and M. Melbye. 1997. 9-year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 349:911-914.
32. Rothbard, J., R. Pemberton, H. Bomdmer, B. A. Askonas, and W. R. Taylor. 1989. Identification of residues necessary for clonal specific recognition of a cytotoxic T cell determinant. EMBO J. 8:2321-2327.
33. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
34. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-1943.
35. Shimojo, N., W. L. Maloy, R. W. Anderson, W. E. Biddison, and J. E. Coligan. 1989. Specificity of peptide binding by the HLA-A2.1 molecule. J. Immunol. 143:2939-2945.
36. Tedder, R. S., T. O'Conner, A. Hughes, H. N'Jie, T. Corrah, and H. Whittle. 1988. Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection. Lancet ii:927-930.
37. Travers, K., S. Mboup, R. Marlink, A. Gueye-Ndiaye, T. Siby, I. Thior, I. Traore, A. Dieng-Sarr, J.-L. Sankale, C. Mullins, I. Ndoye, C.-C. Hsieh, M. Essex, and P. Kanki. 1995. Natural protection against HIV-1 infection provided by HIV-2. Science 268:1612-1615.
38. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.
39. Wilson C. C., S. A. Kalams, B. M. Wilkes, D. J. Ruhl, F. Gao, B. H. Hahn, I. Celine Hanson, K. Luzuriaga, S. Wolinsky, R. Koup, S. P. Buchbinder, R. P. Johnson, and B. D. Walker. 1997. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effect of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 71:1256-1264.
40. Windhagen, A., C. Scholz, P. Hollsberg, H. Fakaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373-380.
41. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705.